Psyence Biomedical Stock (NASDAQ: PBM) stock price, news, charts, stock research, profile.
Open | $0.805 |
Close | $0.798 |
Volume / Avg. | 32.691K / 3.672M |
Day Range | 0.770 - 0.840 |
52 Wk Range | 0.514 - 4.310 |
Market Cap | $11.199M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 7.13% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Psyence Biomedical (NASDAQ: PBM) through any online brokerage.
Other companies in Psyence Biomedical’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Coeptis Therapeutics (NASDAQ:COEP).
There is no analysis for Psyence Biomedical.
The stock price for Psyence Biomedical (NASDAQ: PBM) is $0.8363 last updated April 24, 2024 at 7:55 PM EDT.
There are no upcoming dividends for Psyence Biomedical.
Psyence Biomedical’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Psyence Biomedical.
Psyence Biomedical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.